Pricing
  1. US-listed companies
  2. Avid Bioservices, Inc.
  3. Financials
  4. Depreciation & amortization

Avid Bioservices, Inc. (CDMO)

Market cap
$798.9M
P/E ratio
SummaryFinancials
Period EndDepreciation & amortization (Million USD)YoY (%)
Apr 30, 202411+54.08%
Apr 30, 20237+60.94%
Apr 30, 20224+29.74%
Apr 30, 20213+11.71%
Apr 30, 20203+12.56%
Apr 30, 20193+7.18%
Apr 30, 20183+4.02%
Apr 30, 20172+60.46%
Apr 30, 20162+47.45%
Apr 30, 20151+5.58%
Apr 30, 20141-9.29%
Apr 30, 20131+19.71%
Apr 30, 20121

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat